| Summary | Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making. | Full-service CRO and CDMO with specialized competency centers in drug discovery, formulation development, GMP manufacturing, and bioanalytical services across Germany and France. |
|---|
| Services | - Biostatistics & Statistical Programming
- Data Management & eClinical
- Regulatory Affairs
- Medical Writing
- Computational & In-Silico Drug Discovery
- Translational Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Genetic Toxicology
- Discovery Research
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Preclinical In Vitro Studies
- Preclinical In Vivo Studies
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Phase I Clinical Trials
- Biomarker Assays
- Phase II Clinical Trials
- Phase III Clinical Trials
- Clinical Operations
- Phase IV / Post-Marketing
- US FDA Regulatory Strategy
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy
- China NMPA Regulatory Strategy
- Clinical Trial Services
| - Bioinformatics & Data Science
- Genomics & Sequencing Services
- Oncology Specialty Services
- Translational Research
- ICH Stability Studies
- Analytical Method Development & Validation
- Regulatory Affairs
- Biostatistics & Statistical Programming
- Data Management & eClinical
- Clinical Operations
- Phase II Clinical Trials
- Phase I Clinical Trials
- Clinical Trial Services
- Biomarker Assays
- Bioanalysis
- In Vivo PK / PD Studies
- In Vitro ADME / DMPK
- In Vitro Pharmacology
- Preclinical In Vitro Studies
- Medicinal Chemistry
- High-Throughput Screening
- Discovery Research
- Target Identification & Validation
- Computational & In-Silico Drug Discovery
- Protein Engineering
- CMC Analytical Development
- Stability Testing & Storage
- Quality Control Testing
- Formulation Development
- Process Development
- Technology Transfer
- CMC Regulatory Submission Support
|
|---|
| Locations | - Global network
- Global presence, 30 countries
- Global presence, Multiple, 30 countries, Global
- Global presence, Multiple, 30+ countries
- Global presence, Multiple, 30 countries, International
- Headquarters, Radnor, Pennsylvania, United States
- Global presence, 30 countries
- Global presence, 30+ countries
| - Headquarters & Drug Discovery, Neu-Ulm, Baden-Württemberg, Germany
- Bioanalytical Services, Neu-Ulm, Baden-Württemberg, Germany
- Headquarters & Bioanalytical Services, Neu-Ulm, Baden-Württemberg, Germany
- Headquarters, Neu-Ulm, Baden-Württemberg, Germany
- Drug Discovery Research, Berlin, Berlin, Germany
- Formulation Development & GMP Manufacturing, Sophia Antipolis, Provence-Alpes-Côte d'Azur, France
- Drug Discovery, Berlin, Berlin, Germany
- Formulation & GMP Manufacturing, Sophia Antipolis, Provence-Alpes-Côte d'Azur, France
|
|---|